pancreatic beta islet cell carcinoma

Known as: islet cell, beta, pancreatic carcinoma, Malignant Pancreatic Insulinoma, insulin producing carcinoma 
An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas. Patients exhibit symptoms related to hypoglycemia due to… (More)
National Institutes of Health

Related topics

Related topics

13 relations
Endocrine systemEpithelial CellsEpitheliumGastrointestinal system
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
BACKGROUND Small benign insulinomas are hard to localise, leading to difficulties in planning of surgical interventions. We aimed… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
Review
2011
Review
2011
Radiopeptide imaging and therapy in Europe.
Receptor targeting with radiolabeled peptides has become an important topic, particularly in nuclear oncology. Strong research… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.
UNLABELLED Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor subtype 2 (sst(2)) imaging in… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Is Laparoscopic Resection Adequate in Patients with Neuroendocrine Pancreatic Tumors?
Since the first reports with laparoscopic resection of islet cell tumors in 1996, the experience worldwide is still limited, with… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
CONTEXT AND OBJECTIVE Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET) is a promising method in… (More)
Is this relevant?
2007
2007
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
PURPOSE Although metabolic changes make diagnosis of insulinoma relatively easy, surgical removal is hampered by difficulties in… (More)
Is this relevant?
2005
2005
Malignant Metastatic Insulinoma—Postoperative Treatment and Follow-up
The rarity of malignant insulinoma limits reports on therapeutic strategies and outcome. The treatment and follow-up of 10… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Review
2002
Review
2002
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
In preclinical studies in rats we evaluated biodistribution and therapeutic effects of different somatostatin analogs, [(111)In… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.
For the 60-year period from 1927 through 1986, we assessed the incidence, recurrence, and long-term survival among all Mayo… (More)
Is this relevant?
Highly Cited
1976
Highly Cited
1976
Insulinoma: clinical and diagnostic features of 60 consecutive cases.
Insulinoma is a rare tumor, occurring more often in women and in the older age range. Eighty percent of patients have a single… (More)
Is this relevant?